CN Patent

CN112955157A — 用于降低接受基于铂的化学疗法的小儿患者的耳毒性的方法

Assigned to Oregon Health and Science University · Expires 2021-06-11 · 5y expired

What this patent protects

本文描述了一种用于消除或降低接受基于铂的化学治疗药物的患者的耳毒性的方法。具体地，描述了降低小儿患者的耳毒性的方法。本文所描述的方法包含向有需要的患者施用有效量的硫代硫酸钠以降低耳毒性。

USPTO Abstract

本文描述了一种用于消除或降低接受基于铂的化学治疗药物的患者的耳毒性的方法。具体地，描述了降低小儿患者的耳毒性的方法。本文所描述的方法包含向有需要的患者施用有效量的硫代硫酸钠以降低耳毒性。

Drugs covered by this patent

Patent Metadata

Patent number
CN112955157A
Jurisdiction
CN
Classification
—
Expires
2021-06-11
Drug substance claim
No
Drug product claim
No
Assignee
Oregon Health and Science University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.